Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy

Publisher： Karger

E-ISSN： 1421-9832|218|2|146-150

ISSN： 1018-8665

Source： Dermatology, Vol.218, Iss.2, 2008-10, pp. : 146-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigation of +405 and –460 Polymorphisms of Vascular Endothelial Growth Factor in Psoriasis and Short-Term Responsiveness to Efalizumab Therapy

By  

Dermatology, Vol. 217, Iss. 3, 2008-06 ,pp. : 201-202

Karger

Access to resources Recommend Favorite

Disseminated Eruptive Giant Mollusca Contagiosa in an Adult Psoriasis Patient during Efalizumab Therapy

By  

Dermatology, Vol. 217, Iss. 1, 2008-04 ,pp. : 85-86

Karger

Access to resources Recommend Favorite

Bullous Pemphigoid Occurring during Efalizumab Treatment for Psoriasis: A Paradoxical Auto-Immune Reaction?

By  

Dermatology, Vol. 219, Iss. 1, 2009-03 ,pp. : 89-90

Karger

Access to resources Recommend Favorite

A Short Cycle of Narrow-Band UVB Phototherapy in the Early Phase of Long-Term Efalizumab Can Provide a Quicker Remission of Moderate and Severe Psoriasis: A Pilot Study

By  

Dermatology, Vol. 218, Iss. 4, 2009-03 ,pp. : 321-326

Karger

Access to resources Recommend Favorite

Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers

By  

Dermatology, Vol. 219, Iss. 1, 2009-04 ,pp. : 48-53

Karger

Access to resources Recommend Favorite